<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Neurologic symptoms associated with <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> in children include thrombotic events, unilateral <z:hpo ids='HP_0100022'>movement disorders</z:hpo>, or <z:hpo ids='HP_0002076'>migraine</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We present a 7-year-old girl with bilateral <z:hpo ids='HP_0001138'>optic neuropathy</z:hpo>, cerebral white-matter lesions, and antiphospholipid IgM that responded to <z:chebi fb="0" ids="8382">prednisone</z:chebi> and tended to relapse when it was stopped </plain></SENT>
<SENT sid="2" pm="."><plain>Remission was obtained under maintenance <z:chebi fb="0" ids="50858">corticosteroid</z:chebi> therapy, and the <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> disappeared </plain></SENT>
<SENT sid="3" pm="."><plain>This case suggests a role for <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> in the pathogenesis of <z:hpo ids='HP_0001138'>optic neuropathy</z:hpo> in childhood </plain></SENT>
</text></document>